De Schutter J. W., Park J., Leung C. Y., Gormley P., Lin Y. S., Hu Z., Berghuis A. M., Poirier J., Tsantrizos Y. S. (2014). Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases, J Med Chem, 57(13), 5764-76. Find out more.

Jasmin S. B., Pearson V., Lalonde D., Domenger D., Theroux L., Poirier J. (2014). Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment, Brain Res, 1562, 39-51. Find out more.

Leduc V., De Beaumont L., Theroux L., Dea D., Aisen P., Petersen R. C., Dufour R., Poirier J. (2014). HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study, Mol Psychiatry. Find out more.

Poirier J., Gauthier S. (2014). Alzheimer’s disease. The Complete Introduction, .

Poirier J., Miron J., Picard C. (2014). Pharmacogenomic Approaches to the Treatment of Sporadic Alzheimer Disease using Cholinomimetic Agents, , 51-63.

Poirier J., Miron J., Picard C., Gormley P., Theroux L., Breitner J., Dea D. (2014). Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease, Neurobiol Aging, 35 Suppl 2, S3-10. Find out more.